Bulletin
Investor Alert

Lipocine Inc.

NAS: LPCN

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Lipocine Inc.

After Hours

LPCN
/zigman2/quotes/202742746/composite

$

0.56

Change

+0.0061 +1.11%

Volume

Volume 298

Feb 2, 2023, 7:42 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Today's close

$ 0.52

$ 0.55

Change

+0.03 +5.46%

Day low

Day high

$0.52

$0.56

Open
Open: 0.52

52 week low

52 week high

$0.36

$1.89

Open

Market cap

$46.07M

Average volume

122,439

P/E ratio

11.80

Rev. per Employee

$1.28M

EPS

0.05

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/lpcn

MarketWatch News on LPCN

  1. Lipocine stock price target cut to $2.50 from $4.00 at Ladenburg Thalmann

    8:19 a.m. Nov. 10, 2022

    - Tomi Kilgore

  6. Lipocine shares plummet 35% after FDA fails to approve its testosterone replacement therapy

    6:03 a.m. May 9, 2018

    - Emma Court

  7. Lipocine downgraded to hold from buy at Canaccord

    10:22 a.m. Jan. 11, 2018

    - Tomi Kilgore

  8. Lipocine stock price target cut to $2 from $11 at Canaccord

    10:23 a.m. Jan. 11, 2018

    - Tomi Kilgore

  9. 6 stocks to watch

    2:38 p.m. Sept. 9, 2015

    - The Trading Deck

  10. 4 stocks to watch

    2:21 p.m. Sept. 2, 2015

    - The Trading Deck

  11. Bed Bath & Beyond surges on earnings

    4:39 p.m. Sept. 23, 2014

    - MarketWatch

Analyst Ratings

/news/nonmarketwatch/company/us/lpcn

Other News on LPCN

  2. 10-Q: LIPOCINE INC.

    8:04 a.m. Aug. 8, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. 10-Q: LIPOCINE INC.

    7:06 a.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  5. MVIS, MRIN and CLVR among mid-day movers

    11:46 a.m. March 29, 2022

    - Seeking Alpha

  8. 10-K: LIPOCINE INC.

    8:04 a.m. March 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  13. BGVF, VYNT and SNMP among pre market gainers

    7:38 a.m. Nov. 4, 2021

    - Seeking Alpha

  15. Warning: LPCN is at high risk of performing badly

    3:54 a.m. Oct. 27, 2021

    - Seeking Alpha

  16. AG, FRO and WATT among pre market gainers

    7:33 a.m. Oct. 19, 2021

    - Seeking Alpha

  18. FDA affirms class 1 NDA resubmission for Lipocine's Tlando

    7:35 a.m. Sept. 28, 2021

    - Seeking Alpha

  19. Lipocine discloses mid-stage data for NASH candidate

    7:29 a.m. Aug. 25, 2021

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/lpcn

Press Releases on LPCN

  1. Lipocine to Present at Biotech Showcase

    8:00 a.m. Jan. 5, 2023

    - PR Newswire - PRF

  6. Lipocine to Participate in the Cantor Neurology & Psychiatric Conference

    12:21 p.m. Sept. 27, 2022

    - PR Newswire - PRF

  8. Lipocine to Present at Ladenburg Thalmann 2022 Healthcare Conference

    3:10 p.m. Sept. 22, 2022

    - PR Newswire - PRF

  11. FDA Clears LPCN 2101 IND for Adult Epilepsy Treatment

    7:00 a.m. July 11, 2022

    - PR Newswire - PRF

  12. LIPOCINE GRANTED US PATENTS DIRECTED TO CNS AND LIVER PROGRAMS

    7:00 a.m. June 14, 2022

    - PR Newswire - PRF

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.